{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:59:02Z","timestamp":1773316742074,"version":"3.50.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Hepatitis B virus (HBV) can persist in peripheral blood mononuclear cells (PBMCs) as an extrahepatic reservoir in treatment-naive patients; however, its persistence during long-term nucleos(t)ide analogue therapy with sustained serum viral suppression remains unclear. This study aimed to evaluate the frequency and predictors of HBV DNA detectability in PBMCs of chronic hepatitis B (CHB) patients following long-term nucleos(t)ide analogue therapy\u2013induced sustained serum viral suppression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Eighty-eight CHB patients, on long-term tenofovir disoproxil fumarate (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 44) or entecavir (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 44) with greater than 2 years of sustained viral suppression, were enrolled. PBMCs were tested for HBV DNA by quantitative PCR. Clinical and laboratory data were analyzed to identify predictors of PBMC HBV DNA detection. Receiver operating characteristic analysis assessed the performance of posttreatment serum quantitative hepatitis B surface antigen (qHBsAg).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      HBV DNA was detected in PBMCs of eight (9.1%) patients, equally distributed between treatment groups. Pretreatment hepatitis B e-antigen (HBeAg) positivity predicted PBMC HBV DNA detection (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.036). PBMC HBV DNA-positive patients were older males with worse baseline liver chemistry and advanced fibrosis. Posttreatment qHBsAg was higher in PBMC HBV DNA-positive patients (139.5 vs. 21.5 IU\/ml;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and strongly correlated with PBMC viral load (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = 0.905,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002); qHBsAg greater than 89 IU\/ml predicted PBMC HBV DNA detection with high accuracy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HBV DNA may persist in PBMCs despite long-term nucleos(t)ide analogue therapy\u2013induced sustained viral suppression. Pretreatment HBeAg positivity and elevated posttreatment qHBsAg can help identify patients at risk, highlighting the need to monitor extrahepatic reservoirs in CHB management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/meg.0000000000003136","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:01:21Z","timestamp":1769630481000},"page":"503-510","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Detectability of hepatitis B virus DNA in peripheral blood mononuclear cells following long-term nucleos(t)ide analogue therapy-induced sustained viral suppression"],"prefix":"10.1097","volume":"38","author":[{"given":"Mohamed Zakaria","family":"Abu Rahma","sequence":"first","affiliation":[{"name":"Gastroenterology and Tropical Medicine Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham Ahmed","family":"Hassan","sequence":"additional","affiliation":[{"name":"Gastroenterology and Tropical Medicine Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Farooq Alsayed","family":"Hasanain","sequence":"additional","affiliation":[{"name":"Gastroenterology and Tropical Medicine Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Abdelhady Mohammad","family":"Omar","sequence":"additional","affiliation":[{"name":"Gastroenterology and Tropical Medicine Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Mekky","sequence":"additional","affiliation":[{"name":"Gastroenterology and Tropical Medicine Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"El-Mokhtar","sequence":"additional","affiliation":[{"name":"Medical Microbiology and Immunology Department, Faculty of Medicine, Assiut University, Assiut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani I.","family":"Sayed","sequence":"additional","affiliation":[{"name":"Gastroenterology and Tropical Medicine Department, Faculty of Medicine, Luxor University"},{"name":"Assiut Liver Center, Ministry of Health, Assiut, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"R2-20260311","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2024.12.004","article-title":"The 2024 updated WHO guidelines for the prevention and management of chronic hepatitis B: main changes and potential implications for the next major liver society clinical practice guidelines.","volume":"82","author":"Wong","year":"2025","journal-title":"J Hepatol"},{"key":"R3-20260311","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(16)31018-2","article-title":"The global burden of viral hepatitis: better estimates to guide hepatitis elimination efforts.","volume":"388","author":"Wiktor","year":"2016","journal-title":"Lancet"},{"key":"R4-20260311","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","article-title":"The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.","volume":"388","author":"Raddad","year":"2016","journal-title":"Lancet"},{"key":"R5-20260311","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/14787210.2018.1448709","article-title":"HCV in Egypt, prevention, treatment and key barriers to elimination.","volume":"16","author":"El Kassas","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R6-20260311","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jcv.2017.06.009","article-title":"Compartmental HBV evolution and replication in liver and extrahepatic sites after nucleos\/tide analogue therapy in chronic hepatitis B carriers.","volume":"94","author":"Gao","year":"2017","journal-title":"J Clin Virol"},{"key":"R7-20260311","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/j.gastro.2014.02.024","article-title":"Identification of NTCP as an HBV receptor: the beginning of the end or the end of the beginning?","volume":"146","author":"Tong","year":"2014","journal-title":"Gastroenterology"},{"key":"R8-20260311","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/hep.1840180406","article-title":"Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection.","volume":"18","author":"Mason","year":"1993","journal-title":"Hepatology"},{"key":"R9-20260311","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2893.2010.01321.x","article-title":"Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.","volume":"18","author":"Coffin","year":"2011","journal-title":"J Viral Hepat"},{"key":"R10-20260311","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/lt.22312","article-title":"Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy.","volume":"17","author":"Coffin","year":"2011","journal-title":"Liver Transpl"},{"key":"R11-20260311","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.patbio.2010.02.003","article-title":"A 2010 update on occult hepatitis B infection.","volume":"58","author":"Raimondo","year":"2010","journal-title":"Pathol Biol (Paris)"},{"key":"R12-20260311","doi-asserted-by":"crossref","first-page":"266","DOI":"10.7150\/ijbs.10813","article-title":"Peripheral blood mononuclear cell traffic plays a crucial role in mother-to-infant transmission of hepatitis B virus.","volume":"11","author":"Xu","year":"2015","journal-title":"Int J Biol Sci"},{"key":"R13-20260311","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/jhep.2003.50294","article-title":"HBV DNA persistence 10 years after liver transplantation despite successful anti\u2010HBS passive immunoprophylaxis.","volume":"38","author":"Roche","year":"2003","journal-title":"Hepatology"},{"key":"R14-20260311","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Clinical Practice Guidelines on the management of hepatitis B virus infection.","volume":"67","year":"2017","journal-title":"Hepatology"},{"key":"R15-20260311","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"R16-20260311","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12072-019-09943-6","article-title":"Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results.","volume":"13","author":"Liang","year":"2019","journal-title":"Hepatol Int"},{"key":"R17-20260311","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A global scientific strategy to cure hepatitis B.","volume":"4","author":"Revill","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R18-20260311","first-page":"338","article-title":"AASLD updates chronic hepatitis B recommendations.","volume":"79","author":"Huntzinger","year":"2009","journal-title":"Am Fam Physician"},{"key":"R20-20260311","doi-asserted-by":"crossref","first-page":"e96014","DOI":"10.5812\/hepatmon.96014","article-title":"HBV DNA in the plasma and peripheral blood mononuclear cells in chronic HBV infected individuals who became HBsAg-serocleared or seroconverted.","volume":"19","author":"Masrour-Roudsari","year":"2019","journal-title":"Hepat Mon"},{"key":"R21-20260311","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"R22-20260311","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jhep.2016.04.023","article-title":"Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.","volume":"65","author":"Boursier","year":"2016","journal-title":"J Hepatol"},{"key":"R23-20260311","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43066-020-00043-x","article-title":"Recent advances in non-invasive diagnosis and medical management of non-alcoholic fatty liver disease in adult.","volume":"10","author":"Paul","year":"2020","journal-title":"Egypt. Liver J"},{"key":"R24-20260311","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/v9060156","article-title":"The role of cccDNA in HBV maintenance.","volume":"9","author":"Allweiss","year":"2017","journal-title":"Viruses"},{"key":"R25-20260311","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/17474124.2023.2212161","article-title":"Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis.","volume":"17","author":"Liu","year":"2023","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R26-20260311","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2020.05.042","article-title":"Occult hepatitis B infection and hepatocellular carcinoma: epidemiology, virology, hepatocarcinogenesis and clinical significance.","volume":"73","author":"Mak","year":"2020","journal-title":"J Hepatol"},{"key":"R27-20260311","doi-asserted-by":"crossref","first-page":"e1153","DOI":"10.1097\/IPC.0000000000001153","article-title":"Detectability of hepatitis B virus in peripheral blood mononuclear cells among naive chronic hepatitis B patients with negative viremia: a multicenter study.","volume":"30","author":"Osman","year":"2022","journal-title":"Infect Dis Clin Pract"},{"key":"R28-20260311","first-page":"e10134","article-title":"Prevalence of occult hepatitis B virus in plasma and peripheral blood mononuclear cell compartments of patients with chronic hepatitis C infection in Tehran-Iran.","volume":"13","author":"Vakili Ghartavol","year":"2013","journal-title":"Hepat Mon"},{"key":"R29-20260311","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.3748\/wjg.v12.i25.4061","article-title":"Dynamic changes of HBV DNA in serum and peripheral blood mononuclear cells of chronic hepatitis patients after lamivudine treatment.","volume":"12","author":"Ke","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R30-20260311","doi-asserted-by":"crossref","first-page":"e0137568","DOI":"10.1371\/journal.pone.0137568","article-title":"Detection of hepatitis B virus (HBV) genomes and HBV drug resistant variants by deep sequencing analysis of HBV genomes in immune cell subsets of HBV mono-infected and\/or human immunodeficiency virus type-1 (HIV-1) and HBV co-infected individuals.","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"key":"R31-20260311","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1053\/j.gastro.2004.03.018","article-title":"Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.","volume":"126","author":"Werle-Lapostolle","year":"2004","journal-title":"Gastroenterology"},{"key":"R32-20260311","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/v17030388","article-title":"HBV reactivation in immunosuppressed patients: screening, prevention, and management including solid organ transplant recipients.","volume":"17","author":"Vutien","year":"2025","journal-title":"Viruses"},{"key":"R33-20260311","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1200\/JCO.2014.56.7081","article-title":"Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.","volume":"32","author":"Seto","year":"2014","journal-title":"J Clin Oncol"},{"key":"R34-20260311","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1002\/cncr.28912","article-title":"Impact of sex on the survival of patients with hepatocellular carcinoma: a surveillance, epidemiology, and end results analysis.","volume":"120","author":"Yang","year":"2014","journal-title":"Cancer"},{"key":"R35-20260311","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13148-020-00847-z","article-title":"The signature of HBV-related liver disease in peripheral blood mononuclear cell DNA methylation.","volume":"12","author":"Li","year":"2020","journal-title":"Clin Epigenetics"},{"key":"R36-20260311","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2016.08.022","article-title":"Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B.","volume":"66","author":"Lai","year":"2017","journal-title":"J Hepatol"},{"key":"R37-20260311","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/jhep.2000.8541","article-title":"Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases.","volume":"32","author":"Cabrerizo","year":"2000","journal-title":"Hepatology"},{"key":"R38-20260311","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/HEP.0000000000000431","article-title":"Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference.","volume":"78","author":"Ghany","year":"2023","journal-title":"Hepatology"},{"key":"R39-20260311","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/hep.1840160108","article-title":"Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance.","volume":"16","author":"Mason","year":"1992","journal-title":"Hepatology"},{"key":"R40-20260311","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.gastro.2008.10.026","article-title":"2-Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B.","volume":"136","author":"Liaw","year":"2009","journal-title":"Gastroenterology"},{"key":"R41-20260311","first-page":"e120982","article-title":"Detection and quantification of hepatitis B virus genomes in peripheral blood mononuclear cells of chronic hepatitis B virus infection, cirrhosis, and hepatocellular carcinoma patients.","volume":"21","author":"Poortahmasebi","year":"2021","journal-title":"Hepa Mon"},{"key":"R42-20260311","doi-asserted-by":"crossref","first-page":"1143258","DOI":"10.3389\/fonc.2023.1143258","article-title":"New insights into hepatitis B virus lymphotropism: implications for HBV-related lymphomagenesis.","volume":"13","author":"Svicher","year":"2023","journal-title":"Front Oncol"},{"key":"R43-20260311","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/v14030584","article-title":"HBV-RNA, quantitative HBsAg, levels of HBV in peripheral lymphocytes and HBV mutation profiles in chronic hepatitis B.","volume":"14","author":"Gozlan","year":"2022","journal-title":"Viruses"},{"key":"R44-20260311","doi-asserted-by":"crossref","first-page":"e26315","DOI":"10.1371\/journal.pone.0026315","article-title":"Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells.","volume":"6","author":"Vincent","year":"2011","journal-title":"PLoS One"},{"key":"R45-20260311","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s43066-024-00336-5","article-title":"Correlation between quantitative HBsAg and quantitative HBV DNA in chronic hepatitis B patients: a systematic review and meta-analysis.","volume":"14","author":"Maimunah","year":"2024","journal-title":"Egypt. Liver J"},{"key":"R46-20260311","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.3892\/mmr.2016.4973","article-title":"Hepatitis B virus replication is upregulated in proliferated peripheral blood lymphocytes.","volume":"13","author":"Yan","year":"2016","journal-title":"Mol Med Rep"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000003136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:00:58Z","timestamp":1773252058000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000003136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000003136","relation":{},"ISSN":["1473-5687"],"issn-type":[{"value":"1473-5687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"2025-09-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}